We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharmaceuticals Are Under Microscope in USTR’s Review of India’s Intellectual Property Rights
Pharmaceuticals Are Under Microscope in USTR’s Review of India’s Intellectual Property Rights
The U.S. Trade Representative’s Office has launched a review of India’s intellectual property regime that will focus in large part on pharmaceutical IP issues, including the country’s policy of providing access to affordable medicines.